2279 — Yonghe Medical Co Share Price
Last trade - 00:00- HK$514.77m
- HK$705.07m
- CNY1.80bn
- 57
- 74
- 36
- 60
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 9.28 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | 3.48% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.69 | ||
| Price to Tang. Book | 0.72 | ||
| Price to Free Cashflow | 2.16 | ||
| Price to Sales | 0.27 | ||
| EV to EBITDA | 4.44 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -13.88% | ||
| Return on Equity | -27.32% | ||
| Operating Margin | -9.08% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 1,638.3 | 2,168.58 | 1,412.79 | 1,777.26 | 1,804.5 | 1,849.01 | 2,035.27 | 8.06% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +358.15 | +3.64 | n/a | n/a | n/a | n/a | +216.67 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Yonghe Medical Group Co Ltd is a holding company specializing in hair-related healthcare services. The Company offers one-stop hair-related healthcare services covering hair transplant, medical hair care, routine hair restoration and other ancillary services. The Company has built a brand matrix for the full industry chain which is centered on Yonghe Medical and comprised of Yonghe Hair Transplant for professional hair transplant service, Svenson for medical hair care service, Yonghe Fa Zhi Chu for female aesthetic hair transplant service, and Harvard for medical wig products. The Company also provides medical-grade hair health management service for patients facing hair diseases in a more professional way using medical testing, diagnosis and personalized nursing treatment through Svenson Medical Hair Care Centers. The Company mainly conducts its businesses in China market.
Directors
- Yu Zhang CHM (36)
- Zhimei Han FID (44)
- Hui Zhang EDR (34)
- Donghong Huang DMK (35)
- Xiaolong Li OTH (56)
- Yang Xu OTH (42)
- Ching Ching Leung SEC
- Jiaqi Geng NED (50)
- Feng Zhai NED (53)
- Peng Kuan Chan NID (58)
- Xiaopei Li NID (35)
- Jiping Wang NID (60)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 17th, 2020
- Public Since
- December 13th, 2021
- No. of Employees
- 3,549
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 525,271,416
- Address
- China Nuclear E&C Building, BEIJING, 100020
- Web
- https://www.yonghegroup.cn/
- Phone
- Auditors
- PricewaterhouseCoopers
Upcoming Events for 2279
Similar to 2279
Adicon Holdings
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
Beijing Health (Holdings)
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 24:13 UTC, shares in Yonghe Medical Co are trading at HK$1.00. This share price information is delayed by 15 minutes.
Shares in Yonghe Medical Co last closed at HK$1.00 and the price had moved by -10.71% over the past 365 days. In terms of relative price strength the Yonghe Medical Co share price has underperformed the FTSE Developed Asia Pacific Index by -9.69% over the past year.
The overall consensus recommendation for Yonghe Medical Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreYonghe Medical Co does not currently pay a dividend.
Yonghe Medical Co does not currently pay a dividend.
Yonghe Medical Co does not currently pay a dividend.
To buy shares in Yonghe Medical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$1.00, shares in Yonghe Medical Co had a market capitalisation of HK$514.77m.
Here are the trading details for Yonghe Medical Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2279
Based on an overall assessment of its quality, value and momentum Yonghe Medical Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Yonghe Medical Co is HK$1.63. That is 62.92% above the last closing price of HK$1.00.
Analysts covering Yonghe Medical Co currently have a consensus Earnings Per Share (EPS) forecast of CNY0.06 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Yonghe Medical Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +19.06%.
As of the last closing price of HK$1.00, shares in Yonghe Medical Co were trading +12.12% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Yonghe Medical Co PE ratio based on its reported earnings over the past 12 months is 9.28. The shares last closed at HK$1.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Yonghe Medical Co's management team is headed by:
- Yu Zhang - CHM
- Zhimei Han - FID
- Hui Zhang - EDR
- Donghong Huang - DMK
- Xiaolong Li - OTH
- Yang Xu - OTH
- Ching Ching Leung - SEC
- Jiaqi Geng - NED
- Feng Zhai - NED
- Peng Kuan Chan - NID
- Xiaopei Li - NID
- Jiping Wang - NID